Notably, PRMT1, PRMT2, PRMT3, and PRMT7 exhibited upregulation, while PRMT5, PRMT6, and PRMT8 displayed downregulation in tumor (Figure 1A). This evidence concerns the gene PRMT5 and neoplasm.